Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6977 USD | +0.93% |
|
-8.20% | +36.54% |
10/06 | Lakeshore Biopharma Co., Ltd Announces Executive Changes | CI |
28/05 | YS Biopharma Co., Ltd. will Change its Ticker to LSB from YS | CI |
Sales 2024 * | 596M 82.17M 6.86B | Sales 2025 * | 827M 114M 9.52B | Capitalization | 953M 131M 10.97B |
---|---|---|---|---|---|
Net income 2024 * | -297M -40.93M -3.42B | Net income 2025 * | -122M -16.81M -1.4B | EV / Sales 2024 * | 1.6 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.15 x |
P/E ratio 2024 * |
-1.59
x | P/E ratio 2025 * |
-4.64
x | Employees | 773 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 18.57% |
1 day | +0.93% | ||
1 week | -8.20% | ||
Current month | -16.44% | ||
1 month | -26.57% | ||
3 months | -3.50% | ||
6 months | +43.38% | ||
Current year | +36.54% |
![Extreme 0.68](/images/extremecours_fleche.png)
![Extreme 0.68](/images/extremecours_fleche.png)
![Extreme 0.3503](/images/extremecours_fleche.png)
![Extreme 0.3503](/images/extremecours_fleche.png)
![Extreme 0.3503](/images/extremecours_fleche.png)
![Extreme 0.3503](/images/extremecours_fleche.png)
![Extreme 0.3503](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Hui Shao
CEO | Chief Executive Officer | 55 | 31/20/31 |
Chun Yuan Wu
DFI | Director of Finance/CFO | 46 | 31/20/31 |
Zenaida Mojares
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Viren Mehta
BRD | Director/Board Member | 74 | - |
Hui Shao
CEO | Chief Executive Officer | 55 | 31/20/31 |
Ajit Shetty
CHM | Chairman | 77 | 01/21/01 |
Date | Price | Change | Volume |
---|---|---|---|
14/24/14 | 0.6977 | +0.93% | 19,496 |
13/24/13 | 0.6913 | -4.12% | 45,365 |
12/24/12 | 0.721 | -3.74% | 23,351 |
11/24/11 | 0.749 | +10.15% | 42,073 |
10/24/10 | 0.68 | -10.53% | 69,582 |
Delayed Quote Nasdaq, June 15, 2024 at 02:00 am IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.54% | 131M | |
+0.75% | 92.38B | |
-3.03% | 37.9B | |
-10.46% | 33.73B | |
+73.64% | 27.98B | |
-13.39% | 15.86B | |
-1.08% | 13.97B | |
-11.15% | 11.67B | |
+169.04% | 10.17B | |
-50.19% | 10.04B |
- Stock Market
- Equities
- LSB Stock